Smoking Cessation and Alcohol Use Among Cancer Survivors: Investigating the Efficacy of a Mindfulness-Based Intervention

NCT07447635 NA NOT_YET_RECRUITING

This study will examine the efficacy of Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) compared to standard care among cancer survivors who smoke cigarettes and engage in at-risk alcohol use. Investigators will evaluate implementation outcomes through structured stakeholder interviews across medical centers, cancer-focused organizations, and community-based programs in Florida, and will conduct a cost-assessment and an incremental cost-effectiveness analysis of the two conditions.

Details

Lead sponsor	H. Lee Moffitt Cancer Center and Research Institute
Phase	NA
Status	NOT_YET_RECRUITING
Enrolment	600
Start date	2026-07
Completion	2029-12

Conditions

• Smoking Cessation
• Alcohol Use

Interventions

• Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA)
• Quitline Support

Primary outcomes

• Biochemically Confirmed 7-Day Point Prevalence Smoking Abstinence — 6 months post treatment
  Self-reported no combustible tobacco use in the past 7 days, verified with saliva cotinine \<10 ng/mL.
• Percent Heavy Drinking Days (Past 4 Weeks) — 6 months post treatment
  Percentage of days in the past 4 weeks meeting heavy drinking criteria (≥5 drinks for men; ≥4 drinks for women)

Countries

United States